Otto Aufranc奖:全髋关节置换术中骨内注射万古霉素——组织浓度更优且效率提高
这项单盲随机对照试验于2020年12月至2022年5月纳入20例患者,比较静脉万古霉素(15 mg/kg)与骨内注射万古霉素(500 mg/100cc生理盐水)在全髋关节置换术中的血清与局部组织浓度。骨内组血清万古霉素水平在切口时和缝合时均显著低于静脉组,所有局部组织样本浓度更高,髋臼骨磨屑中显著升高,股骨髓内骨接近显著。作者认为骨内万古霉素可用于初次全髋关节置换术,并可能考虑用于其他无止血带手术的抗生素给药。
要点
- 骨内组血清万古霉素水平在切口时和缝合时均显著低于静脉组。
- 骨内组所有局部组织样本万古霉素浓度均高于静脉组。
- 髋臼骨磨屑中浓度显著升高,股骨髓内骨接近显著。
核心结论
- 这项研究证明骨内注射万古霉素在初次全髋关节置换术中具有提高局部组织浓度和降低全身浓度的效用。
- 在无止血带使用的情况下取得阳性结果,作者认为骨内给药可考虑用于其他手术的抗生素递送。
研究设计与样本
- 单盲随机对照试验,于2020年12月至2022年5月进行,共20例患者随机分为两组。
- 静脉万古霉素组按常规给予15 mg/kg,骨内万古霉素组在切开时向大转子注射500 mg/100cc生理盐水。
- 在切开时和缝合时采集血清万古霉素水平,从臀大肌(手术开始和结束时)和髋臼软垫组织采集软组织万古霉素水平,从股骨头、髋臼磨屑和髓内骨采集骨万古霉素水平。
- 追踪局部/全身不良反应、30天并发症和90天并发症。
主要发现
- 骨内组与静脉组相比,在手术开始和结束时血清万古霉素水平均出现统计学显著降低。
- 所有局部组织样本中骨内组万古霉素浓度均更高。
- 髋臼骨磨屑中浓度出现统计学显著升高,股骨髓内骨中接近显著。
临床怎么用
- 作者认为,基于在无止血带使用区域取得的阳性发现,骨内给药可考虑用于其他手术的抗生素递送。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Literature shows that intraosseous (IO) infusions are capable of providing increased local concentrations compared to those administered via intravenous (IV) access. Successes while using the technique for antibiotic prophylaxis administration in total knee arthroplasty (TKA) prompted consideration for use in total hip arthroplasty (THA) however; no study exists for the use of IO vancomycin in THA. METHODS: This single-blinded randomized control trial was performed from December 2020 to May 2022. Twenty patients were randomized into 1 of 2 groups: IV vancomycin (15 mg/kg) given routinely, or IO vancomycin (500 mg/100cc of NS) injected into the greater trochanter during incision. Serum vancomycin levels were collected at incision and closure. Soft tissue vancomycin levels were taken from the gluteus maximus (at start and end of case), and acetabular pulvinar tissue. Bone vancomycin levels were taken from the femoral head, acetabular reamings, and intramedullary bone. Adverse local/systemic reactions, 30-day complications, and 90-day complications were also tracked. RESULTS: A statistically significant reduction in serum vancomycin levels was seen when comparing IO to IV vancomycin at both the start and at the end of the procedure. All local tissue samples had higher concentrations of vancomycin in the IO group. Statistically significant increases were present within the acetabular bone reamings, and approached significance in intramedullary femoral bone. CONCLUSION: This study demonstrates the utility of IO vancomycin in primary THA with increased local tissue and decreased systemic concentrations. With positive findings in an area without tourniquet use, IO may be considered for antibiotic delivery for alternative procedures.
引用
- Harper KD, Park KJ, Brozovich AA, et al. Otto Aufranc Award: Intraosseous Vancomycin in Total Hip Arthroplasty - Superior Tissue Concentrations and Improved Efficiency. J Arthroplasty. 2023. PMID: 37088221. doi:10.1016/j.arth.2023.04.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。